Gland Pharma Limited
Nifty 500
Smallcap 50
Smallcap 100
Smallcap 250
₹2,935.90
-0.37%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.03.
- Comfortable interest cover: operating profit covers interest about 49.4 times.
- Return on equity is moderate at 10.7%.
- Return on capital employed is healthy at 15.1%.
- Net profit margin is strong at 16%.
- Sales have compounded about 13% a year over five years.
- Pays a dividend (yield about 0.68%).
- Promoters hold a majority stake (51.77%).
!Watch-points
- Profit growth has been slow over five years (about 1% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreSafe zone
4.44
In Altman’s original study, companies in this range showed a low incidence of financial distress.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreStrong
7 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 48,433 Cr
Current Price₹ 2,935.90
High / Low₹ 3,042.00 / 1,573.60
Stock P/E42.93507
Book Value₹ 629.00
Dividend Yield0.68%
ROCE15.10%
ROE10.70%
Face Value₹ 1.00
Debt to Equity0.03
PEG Ratio5.26
EV / EBITDA23.61
Industry PE35.70
P/B Ratio4.669921
EPS₹ 62.35
Debt₹ 284 Cr
PAT Margin15.97%
Cash PAT₹ 1,451 Cr
ICR49.39
Promoter Holding51.77%
FII Holding8.74%
DII Holding30.44%
Public Holding9.06%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity